XNAS · DFTX
-3.41% · -$1.65 · Vol 2.6M
Market closed · last close 4:00 PM ET · price as of 17:37:30 ET
Definium Therapeutics, Inc. Common Shares

Definium Therapeutics, Inc. Common Shares

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
$46.80
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is DFTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for DFTX are being assembled.
About Definium Therapeutics, Inc. Common Shares
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed since
2020
Employees
106
Country
US

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$47.73
Day high
$48.39
Day low
$44.52
Previous close
$48.45
52W high
$48.39
-3.29% from high
52W low
$44.52
59% of range
Market cap
$6.4B
EPS
$-2.8400
Shares out
132.7M
Volume
2.6M
VWAP
$46.27
Price history computed in-house
SMA 50 $46.96 · below
SMA 200 $46.96 · below
52W position 59%
Veridion warehouse edge

Warehouse intelligence for DFTX.

Veridion Score
65
0: 221: 522: 913: Not reported4: Not reported5: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

DFTX insider activity

Definium Therapeutics, Inc. Common Shares

Score
Coverage building
Pressure
Net selling
Filings
8
Buys / sells
0 / 8
Net value
-$3.4M
Insiders
5
Named filers
KD
Karlin Daniel
Insider
Leadership
BR
Barrow Robert
Insider
Leadership
WT
Wiley Matthew T.
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$3.4M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-262026-06-25Karlin DanielInsidersell$45.0310,035503,282$452KSEC Form 4
2026-06-262026-06-25Barrow RobertInsidersell$45.0329,2081,098,246$1.3MSEC Form 4
2026-06-262026-06-25Wiley Matthew T.Insidersell$45.032,867174,633$129KSEC Form 4
2026-06-262026-06-25Roberts BrandiInsidersell$45.033,013209,487$136KSEC Form 4
2026-06-262026-06-25Sullivan MarkInsidersell$45.0313,008320,571$586KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 3 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

DFTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DFTX in this window.
Lobbying spend

DFTX lobbying filings, year to date.

Registered lobbying filings matched to Definium Therapeutics, Inc. Common Shares.

$100.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$100.0K
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)

DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)

Apr 15, 2026
Latest news · DFTX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for DFTX.
Options
Sovereign unlock shows live options positioning for DFTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.